Digital Biomarkers and Digital Measurements Summit 2020
What Level of Evidence is Needed to Evaluate Biomarkers and Measurements?
ActiGraph CEO, Jeremy Wyatt joins a panel of experts from HumanFirst, Atlantic Council, and Samsung NeuroLogica take a deep dive and answer key questions into the evaluation of digital biomarkers and digital measurements during the discussion "What Level of Evidence is Needed to Evaluate Biomarkers and Measurements?”
